Cell Signaling Technology Inc. (CST)

Cell Signaling Technology, founded in 1999 by New England Biolabs, supplies high-quality reagents for the study of cell signaling processes. Dedicated to providing excellent products, technical support, and customer service, CST's focus lies on the development of novel antibodies and related research tools. Our product line includes specific antibodies for the detection of activated kinases and caspases as well as antibodies against non-activated enzymes, non-radioactive kinase assay kits, and kinase substrate and inhibitors. CST's products are generated in their laboratories by a team of dedicated scientists and undergo rigorous Quality Assurance testing. All products are produced with both the academic researcher and the industrial scientist involved in drug discovery and proteomics in mind.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Bio
- Enzymes
- Reagents
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: